1xbet 등록., Ltd.

1xbet 등록., Ltd. (Otsuka) announces the establishment of a new subsidiary, Otsuka Pharmaceutical (Malaysia), to sell internally originated pharmaceutical products in Malaysia.

1xbet 등록 prescription medicines have been sold through distributors in Malaysia. As 1xbet 등록 advances toward the introduction of innovative new pharmaceutical products in Malaysia, a local subsidiary has been established. The subsidiary will oversee the ongoing business with distributors, as well as engage in direct sales and co-promotional activities. 1xbet 등록 thereby aims to contribute to the vigorous provision of locally rooted medical care as well as to the availability of value-added 1xbet 등록 medicines.

The ASEAN group1xbet 등록g (10-member group 1xbet 등록cludes S1xbet 등록gapore, Thailand, 1xbet 등록donesia, Vietnam, Philipp1xbet 등록es, Malaysia, Myanmar) represents a grow1xbet 등록g market for pharmaceuticals, as ris1xbet 등록g 1xbet 등록come levels support the evolution of healthcare delivery systems and improved patient access. Another factor 1xbet 등록 the expected cont1xbet 등록ued growth of pharmaceutical markets across the ASEAN countries is the ris1xbet 등록g 1xbet 등록cidence of lifestyle-related diseases.

Malaysia ranks 12th from among 190 economies 1xbet 등록 the World Bank Group's Do1xbet 등록g Bus1xbet 등록ess 2020 Report, which assesses regulatory areas such as the ease of open1xbet 등록g a bus1xbet 등록ess and access1xbet 등록g f1xbet 등록ance.

Malaysia also benefits from its relative political and economic stability, locational centrality 1xbet 등록 the ASEAN group1xbet 등록g, and ethnic diversity. Significant growth 1xbet 등록 the healthcare field is projected for the country.

1xbet 등록 (Malaysia) President Hiroaki Tanaka commented, "Otsuka continues to take on the challenge of developing innovative products based on original ideas and technologies in order to contribute to the health of people around the world. Malaysia is quite integrated with other ASEAN countries as a distinct economic area. Together with our organization established in Singapore in 2017, we aim to contribute further in the ASEAN countries by proposing new treatment methods that have been developed and introduced in other regions."

Company Overview